Skip to main content
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.
Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia.
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project.
Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).
Postoperative radiation therapy for low-grade glioma: patterns of care between 1998 and 2006.
Response, survival, and toxicity after iodine-131-metaiodobenzylguanidine therapy for neuroblastoma in preadolescents, adolescents, and adults.